0000905148-23-001029.txt : 20230928
0000905148-23-001029.hdr.sgml : 20230928
20230928191749
ACCESSION NUMBER: 0000905148-23-001029
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230926
FILED AS OF DATE: 20230928
DATE AS OF CHANGE: 20230928
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Miller Mary
CENTRAL INDEX KEY: 0001841088
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41551
FILM NUMBER: 231291368
MAIL ADDRESS:
STREET 1: C/O BUTTERFLY NETWORK, INC.
STREET 2: 530 OLD WHITFIELD STREET
CITY: GUILFORD
STATE: CT
ZIP: 06437
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Acrivon Therapeutics, Inc.
CENTRAL INDEX KEY: 0001781174
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 825125532
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 480 ARSENAL WAY, SUITE 100
CITY: WATERTOWN
STATE: MA
ZIP: 02472
BUSINESS PHONE: 617-207-8979
MAIL ADDRESS:
STREET 1: 480 ARSENAL WAY, SUITE 100
CITY: WATERTOWN
STATE: MA
ZIP: 02472
4
1
form4.xml
X0508
4
2023-09-26
0001781174
Acrivon Therapeutics, Inc.
ACRV
0001841088
Miller Mary
C/O ACRIVON THERAPEUTICS, INC.
480 ARSENAL WAY, SUITE 100
WATERTOWN
MA
02472
true
Chief Legal Officer
false
Common Stock
2023-09-26
4
A
0
3858
0
A
44287
D
Stock Option (Right to Buy)
8.95
2023-09-26
4
A
0
11576
0
A
2033-09-25
Common Stock
11576
11576
D
These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Of these RSUs, twenty-five percent (25%) shall vest on October 1, 2024, and the remaining RSUs shall vest in three substantially equal annual installments thereafter, in each case subject to the Reporting Person's continuous service through each such vesting date.
Twenty-five percent (25%) of the shares subject to the option shall vest on October 1, 2024, and the remaining shares subject to the option shall vest in 36 substantially equal monthly installments thereafter, in each case subject to the Reporting Person's continuous service through each such vesting date.
/s/ Rasmus Holm-Jorgensen, Attorney-in-Fact
2023-09-28